The estimated Net Worth of Christopher L Gaenzle is at least $16.5 Milion dollars as of 17 June 2021. Mr. Gaenzle owns over 27,497 units of PRA Health Sciences Inc stock worth over $10,242,524 and over the last 8 years he sold PRAH stock worth over $6,301,433. In addition, he makes $0 as Executive Vice President, Chief Administrative Officer a General Counsel at PRA Health Sciences Inc.
Sign up
Mr. Gaenzle PRAH stock SEC Form 4 insiders trading
Christopher has made over 14 trades of the PRA Health Sciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 27,497 units of PRAH stock worth $2,773,897 on 17 June 2021.
The largest trade he's ever made was exercising 42,601 units of PRA Health Sciences Inc stock on 1 September 2017 worth over $572,983. On average, Christopher trades about 8,511 units every 91 days since 2016. As of 17 June 2021 he still owns at least 61,997 units of PRA Health Sciences Inc stock.
You can see the complete history of Mr. Gaenzle stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Gaenzle biography
Christopher L. Gaenzle serves as Executive Vice President, Chief Administrative Officer, General Counsel of the Company. Mr. Gaenzle joined PRA in April 2019 and serves as Executive Vice President, Chief Administrative Officer and General Counsel of the Company. Mr. Gaenzle has a strong background and expertise in leading large, multi-faceted, and global teams through exceptional growth. As Chief Administrative Officer and General Counsel, he oversees human resources, talent acquisition, quality assurance, compliance, and legal, in addition to data privacy and cybersecurity. Mr. Gaenzle previously served as Chief Administrative Officer, General Counsel and Corporate Secretary at Syneos Health, Inc. (previously INC Research, Inc.) from August 2013 to April 2018, and as General Counsel & Corporate Secretary from April 2012 to April 2018. He has also held leadership roles at Pfizer Inc. and Hunton Andrews Kurth LLP, formery Hunton & Williams LLP.
How old is Christopher Gaenzle?
Christopher Gaenzle is 53, he's been the Executive Vice President, Chief Administrative Officer a General Counsel of PRA Health Sciences Inc since 2019. There are 6 older and 4 younger executives at PRA Health Sciences Inc. The oldest executive at PRA Health Sciences Inc is Jeffrey Barber, 67, who is the Independent Director.
What's Christopher Gaenzle's mailing address?
Christopher's mailing address filed with the SEC is 3201 Beechleaf Ct, Raleigh, NC 27604, USA.
Insiders trading at PRA Health Sciences Inc
Over the last 10 years, insiders at PRA Health Sciences Inc have traded over $5,843,308,181 worth of PRA Health Sciences Inc stock. The most active insiders traders include Fund Holdings L.P.Kkr Fund ..., Fund Holdings L.P.Kkr Fund ... a Pra Investors L.P.Kkr Pra I.... On average, PRA Health Sciences Inc executives and independent directors trade stock every 39 days with the average trade being worth of $280,602,577. The most recent stock trade was executed by Christopher L Gaenzle on 17 June 2021, trading 27,497 units of PRAH stock currently worth $2,773,897.
What does PRA Health Sciences Inc do?
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
What does PRA Health Sciences Inc's logo look like?
Complete history of Mr. Gaenzle stock trades at PRA Health Sciences Inc a Syneos Health Inc
PRA Health Sciences Inc executives and stock owners
PRA Health Sciences Inc executives and other stock owners filed with the SEC include:
-
Colin Shannon,
Chairman of the Board, President, Chief Executive Officer -
Michael Bonello,
Chief Financial Officer, Executive Vice President -
Colin Shannon,
Chairman, CEO & Pres -
Linda Grais,
Independent Director -
Jeffrey Barber,
Independent Director -
Matthew Young,
Independent Director -
Alexander Dickinson,
Independent Director -
James Momtazee,
Lead Independent Director -
Glen Stettin,
Independent Director -
Christopher Gaenzle,
Executive Vice President, Chief Administrative Officer, General Counsel -
Dr. Michael Kirchengast,
Sr. VP of Scientific Affairs -
Patrick R. Spine,
VP of HR -
Tami Klerr-Naivar,
Exec. VP and Chief Sales & Marketing Officer -
Laurie Hurst,
Sr. Director of Communications & PR -
Thomas Byrne,
VP of Legal Affairs -
Kent Thoelke,
Exec. VP & Chief Scientific Officer -
Margaret Keegan,
Exec. VP & COO -
Pra Investors L.P.Kkr Pra I...,
-
Fund Holdings L.P.Kkr Fund ...,
-
Fund Holdings L.P.Kkr Fund ...,
-
David W Dockhorn,
Executive VP & CCO -
Linda Baddour,
Executive VP & CFO -
Pra Investors L.P.Kkr Pra I...,
-
Group Ltd Kkr Group Holding...,
-
Fund Holdings L.P.Kkr Fund ...,